Stylus Medicine
- Employees
- 11–50
- Business Model
- B2B
- Website
- stylusmedicine.com
- Last Round
- Series AMay 2025
- Rounds
- 2
About
Stylus Medicine develops transformative in vivo genetic medicines using engineered recombinases and non-viral delivery to unlock cures.
Summary
Stylus Medicine is a Biotech company based in United States. Its most recent funding was a Series A round in May 2025. Investors include RA Capital Management, Khosla Ventures and Eli Lilly.
Tech & App Stack
1 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
May 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...